| Insurance Industry | Financials Sector | Ms. Maryam Marissen CEO | XMUN Exchange | - ISIN |
| Canada Country | - Employees | - Last Dividend | 14 Nov 2024 Last Split | - IPO Date |
PanGenomic Health Inc. is recognized as a frontrunner in the precision health industry, focusing on the development of innovative solutions aimed at enhancing mental wellness through natural remedies and advanced health-tracking technologies. The company, which was initially established under the name Zetta Capital Corp., underwent a strategic rebranding to PanGenomic Health Inc. in December 2021 to better reflect its expanded focus on genomic and precision health. Since its incorporation in 2015, PanGenomic Health Inc. has been dedicated to its mission from its headquarters in Vancouver, Canada, heralding a new era of personalized health care tailored to individual needs.
Developed by PanGenomic Health Inc., the Nara App stands as a pivotal tool in the realm of mental health, offering users personalized natural remedies aimed at bolstering mental wellness. This innovative application leans on the potential of curated suggestions to help individuals navigate through their mental health journeys with ease and effectiveness.
Mindleap serves as a comprehensive mental health tracker, setting itself apart with its unique offering of accessible audio content, insightful blogs, and professional services designed to support mental well-being. This platform is especially tailored to those seeking a holistic view of their mental health, providing valuable tools and resources for improved self-awareness and care.
The MUJN platform represents a groundbreaking approach to health and wellness insights, merging point-of-care biomarker testing with structured symptom tracking. This fusion of technology and personalized health care allows individuals to gain a deeper understanding of their own wellness, empowering them with the knowledge needed to make informed decisions about their health journey.